Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Ethyl 2-bromoisovalerate → ethyl (+/-)-5-dodecyl-alpha-(1-methylethyl)-2H-tetrazole-2-acetate
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Ethyl 2-bromoisovalerate | HCID 79068 | — |
| 반응물 | Ethyl 2-(2-bromophenyl)acetate | HCID 2780092 | — |
| 반응물 | HCID 178442802 | HCID 178442802 | — |
| 반응물 | HCID 178442834 | HCID 178442834 | — |
| 생성물 | ethyl (+/-)-5-dodecyl-alpha-(1-methylethyl)-2H-tetrazole-2-acetate | HCID 53709467 | — |
반응 단계
When in the general procedure of Example 71 an appropriate amount of 5-dodecyl-1H-tetrazole was substituted for 5-decyl-1H-tetrazole and an appropriate amount of ethyl-2-bromo-3-methylbutyrate was substituted for ethyl 2-bromophenylacetate, the title compound was obtained. 1H NMR (CDCl3): δ5.26-5.23 (d, 1H); 4.29-4.19 (q, 2H); 2.94-2.77 (m, 3H); 1.82-1.70 (m, 2H); 1.31-1.20 (m, 21H); 1.08-1.05 (d, 3H); 0.97-0.95 (d, 3H) and 0.90-0.85 (t, 3H) ppm.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US05646170 |
| 출처 데이터셋 | uspto-grants-1997_07 |
| ORD ID | ord-7fe5cc12a8cb4273a632b97357691aaf |
| 출처 메모 | uspto-grants-1997_07 |